AbbVie Bid for Biotech Could Expand with Experimental Drug
AbbVie is exploring a cash purchase of about $10.9 billion for a biotech developing an experimental eczema drug, a mo...
Comparison of dominant fund strategies for retirement, weighing SP 500 versus Total Market to guide your decision.
28,607 articlesAbbVie is exploring a cash purchase of about $10.9 billion for a biotech developing an experimental eczema drug, a mo...
Bitcoin is pulling back from its peak, a move many investors fear. History, though, suggests cycles, patience, and di...
Hycroft Mining and Silvercorp Metals jumped in today's session as gold and silver miners rally on heightened geopolit...
A colossal DeFi trade on AAVE's swap interface left a trader facing a near $50 million loss after a mispriced swap. R...
Carvana remains a high-risk trade due to debt and cyclical demand. Two safer picks, Kinder Morgan and Regions Financi...
A handful of iconic dividend payers have fallen this year, but market watchers see potential upside as earnings stay ...
A celebrity-backed beverage launch sparked a broader lesson in money management. This piece breaks down how holland’s...
Oil prices stay stubbornly high, impacting energy bills and Bitcoin mining. This guide explains why soaring prices ar...
A tiny $1,800 token purchase has triggered a governance attack on Moonwell, risking over $1 million in funds. Analyst...
A year after the OBBBA package, the impact on budgets and balance sheets is mixed. Here's a data-driven read on who g...
SanDisk’s flash-storage division posted stronger-than-expected results as data-center demand and AI workloads surge. ...
Robinhood Chain has posted $816,000 in gross revenue since its July 1 launch, with 89% going to Robinhood, 10% to Arb...